ArticleAdvances in therapy2025
Cost-effectiveness Analysis of COVID-19 mRNA XBB.1.5 Fall 2023 Vaccination in the Netherlands.
Florian Zeevat et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleAdvances in therapy2025
Florian Zeevat et al.PubMed ↗Publisher ↗
No numbers read from the abstract.